QNTM (Quantum BioPharma) Company Net Assets

Public company logo of Quantum BioPharma (QNTM)

The market trend for Quantum BioPharma Ltd (QNTM) demonstrates the dynamics of an asset currently valued at 0.01. Business risks are linked to the allocation of funds across various projects and the probability of trial failures. Quantum BioPharma Ltd (QNTM) integrates a network of medical centers with the development of chronic pain medications. The company's resilience relies on the success of its R&D efforts and strict expense monitoring until stable revenue is achieved.

QNTM Quantum BioPharma Corp Book Capitalization (08/16/2024 - 10/27/2026)

Metric breakdowns and analytics for Quantum BioPharma (QNTM)

- price and consensus price forecast:
Price Quantum BioPharma Corp|QNTM - Price Target Chart
- market capitalization data:
Market Valuation Quantum BioPharma Ltd.|QNTM - Total Company Value
- book capitalization data:
Share Book Value Quantum BioPharma|QNTM - Book Capitalization|Market Value to Book Value quantumbiopharma.com|QNTM - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Quantum BioPharma Ltd|QNTM - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Quantum BioPharma Ltd.|QNTM - Company Debts|Debt to Book Value Quantum BioPharma Ltd.
Fundamental valuation:QNTM - Quantum BioPharma Corp
Flagship merchandise of Quantum BioPharma Ltd.

This metric reflects the difference between total assets and liabilities, demonstrating the real value of equity through the lens of net cash flow. For Quantum BioPharma Ltd (QNTM), amid a period of declining M&A activity and cost optimization, the firm's current book capitalization serves as an indicator of business resilience, allowing for an assessment of internal resource revision efficiency and debt load risks.

Competitor analysis for Quantum BioPharma Ltd

HLN: Total Net Assets|KVUE (Kenvue Inc.) - Company Book Value|VRNA (veronapharma.com) - Company Net Assets|Company Book Value Jyong Biotech MENS|Net Asset Value Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Book Capitalization|Accounting Value of Company Perrigo Corp (PRGO)|Book Capitalization ALVO (Alvotech)|liquidia.com - Book Capitalization|Company Book Value Galapagos (GLPG)|ANIP: Accounting Value of Company|MNKD (MannKind Corp.) - Company Book Value|Amphastar Corp (AMPH) - Company Net Assets|PCRX (Pacira BioSciences) - Book Capitalization|Book Capitalization ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Company Net Assets|Accounting Value of Company AQST (Aquestive Therapeutics Inc)|SCPH: Company Book Value|TECX - Total Stockholders' Equity|Company Net Assets Tonix Pharmaceuticals TNXP|SXTC - Total Net Assets|Book Capitalization eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Accounting Value of Company|Book Capitalization EXOZ (Invizyne Technologies, Inc.)|Total Stockholders' Equity ORMP|Entera Bio Ltd. (ENTX) - Company Book Value|Accounting Value of Company HYFT (ipatherapeutics.com)|ABVC (ABVC BioPharma, Inc.) - Company Book Value|CPIX - Book Value of Business|FibroGen Corp - Company Net Assets|TELO - Book Capitalization|RANI: Book Capitalization|SNYR (Synergy CHC) - Book Capitalization|Company Book Value Rallybio Corp (RLYB)|Accounting Capitalization Lexaria (LEXX)|Company Net Assets Pulmatrix Corp|Total Net Assets ftzy.com.cn PTHL|Company Net Assets APM (Aptorum Group)|lyratherapeutics.com - Book Capitalization|IBO: Company Book Value|TNF Pharmaceuticals (TNFA) - Company Net Assets|Company Net Assets cbdmd.com YCBD|PainReform Corp (PRFX) - Accounting Value of Company|Book Capitalization Altamira Therapeutics Ltd|Company Book Value lipella.com|OPTN (OptiNose) - Book Capitalization|Book Valuation of Business PIRS (Pieris Pharmaceuticals Inc)|PROC: Company Book Value|Petros Pharma - Total Stockholders' Equity|Company Book Value Qilian International|SLRN - Net Asset Value|Book Capitalization TFF Pharmaceuticals, Inc. TFFP